Akebia Therapeutics
AKBA
AKBA
126 hedge funds and large institutions have $282M invested in Akebia Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less call options, than puts
Call options by funds: $1.52M | Put options by funds: $1.8M
29% less capital invested
Capital invested by funds: $399M → $282M (-$118M)
50% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 22
Holders
126
Holding in Top 10
1
Calls
$1.52M
Puts
$1.8M
Top Buyers
| 1 | +$8.23M | |
| 2 | +$6.34M | |
| 3 | +$5.33M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$3.06M |
| 5 |
BlackRock
New York
|
+$2.53M |
Top Sellers
| 1 | -$40.7M | |
| 2 | -$7.47M | |
| 3 | -$3.77M | |
| 4 |
Morgan Stanley
New York
|
-$3.42M |
| 5 |
Renaissance Technologies
New York
|
-$2.53M |